Scott Dodds

Array ( [id] => 7475105 [patent_doc_number] => 20040122210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'GLP-2 compounds, formulations, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/685368 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 67110 [patent_no_of_claims] => 77 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122210.pdf [firstpage_image] =>[orig_patent_app_number] => 10685368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 23808 [patent_doc_number] => 07795203 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Method for topical treatment of eye disease and composition and device for said treatment' [patent_app_type] => utility [patent_app_number] => 10/480724 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5955 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/795/07795203.pdf [firstpage_image] =>[orig_patent_app_number] => 10480724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7280369 [patent_doc_number] => 20040062746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof' [patent_app_type] => new [patent_app_number] => 10/669597 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23754 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20040062746.pdf [firstpage_image] =>[orig_patent_app_number] => 10669597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281264 [patent_doc_number] => 20040063641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Use of growth hormone or a growth hormone secretagogue for promoting bone formation' [patent_app_type] => new [patent_app_number] => 10/669538 [patent_app_country] => US [patent_app_date] => 2003-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8126 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063641.pdf [firstpage_image] =>[orig_patent_app_number] => 10669538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7010221 [patent_doc_number] => 20050063937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Multiple-arm peptide compounds, methods of manufacture and use in therapy' [patent_app_type] => utility [patent_app_number] => 10/664697 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23425 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20050063937.pdf [firstpage_image] =>[orig_patent_app_number] => 10664697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 448676 [patent_doc_number] => 07250396 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-31 [patent_title] => 'Juvenile hormone compositions and methods for making same' [patent_app_type] => utility [patent_app_number] => 10/658789 [patent_app_country] => US [patent_app_date] => 2003-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 10821 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250396.pdf [firstpage_image] =>[orig_patent_app_number] => 10658789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6971322 [patent_doc_number] => 20050037032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Composition and method of treatment for urogenital conditions' [patent_app_type] => utility [patent_app_number] => 10/659053 [patent_app_country] => US [patent_app_date] => 2003-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10467 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037032.pdf [firstpage_image] =>[orig_patent_app_number] => 10659053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7226467 [patent_doc_number] => 20050261472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Binding moieties for fibrin' [patent_app_type] => utility [patent_app_number] => 10/649229 [patent_app_country] => US [patent_app_date] => 2003-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25138 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261472.pdf [firstpage_image] =>[orig_patent_app_number] => 10649229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 899728 [patent_doc_number] => 07338807 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-04 [patent_title] => 'Screening assays for compounds that cause apoptosis' [patent_app_type] => utility [patent_app_number] => 10/633789 [patent_app_country] => US [patent_app_date] => 2003-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 12071 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/338/07338807.pdf [firstpage_image] =>[orig_patent_app_number] => 10633789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 243324 [patent_doc_number] => 07589058 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-15 [patent_title] => 'Ghrelin analogs' [patent_app_type] => utility [patent_app_number] => 10/522398 [patent_app_country] => US [patent_app_date] => 2003-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21531 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/589/07589058.pdf [firstpage_image] =>[orig_patent_app_number] => 10522398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7356169 [patent_doc_number] => 20040013692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Use of botulinum toxins for treating various disorders and conditions and associated pain' [patent_app_type] => new [patent_app_number] => 10/621978 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4291 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20040013692.pdf [firstpage_image] =>[orig_patent_app_number] => 10621978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7290777 [patent_doc_number] => 20040110689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Methods for treating hormone associated conditions using a combination of LHRH antagonists and specific estrogen receptor modulators' [patent_app_type] => new [patent_app_number] => 10/619684 [patent_app_country] => US [patent_app_date] => 2003-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10179 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110689.pdf [firstpage_image] =>[orig_patent_app_number] => 10619684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7134782 [patent_doc_number] => 20040043442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Use of betaine in functional products having blood pressure lowering effects' [patent_app_type] => new [patent_app_number] => 10/617974 [patent_app_country] => US [patent_app_date] => 2003-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4326 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043442.pdf [firstpage_image] =>[orig_patent_app_number] => 10617974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4500585 [patent_doc_number] => 07919455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-05 [patent_title] => 'Marked peptides having affinity for a phospholipid and uses' [patent_app_type] => utility [patent_app_number] => 10/518382 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11944 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/919/07919455.pdf [firstpage_image] =>[orig_patent_app_number] => 10518382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4583675 [patent_doc_number] => 07851440 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-14 [patent_title] => 'Peptides with affinity for a phospholipid and uses' [patent_app_type] => utility [patent_app_number] => 10/518383 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8841 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/851/07851440.pdf [firstpage_image] =>[orig_patent_app_number] => 10518383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6912863 [patent_doc_number] => 20050176621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Crystalline compositions for controlling blood glucose' [patent_app_type] => utility [patent_app_number] => 10/600031 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12680 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176621.pdf [firstpage_image] =>[orig_patent_app_number] => 10600031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7678086 [patent_doc_number] => 20040151740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Botulinum toxin treatment for blepharospasm' [patent_app_type] => new [patent_app_number] => 10/461829 [patent_app_country] => US [patent_app_date] => 2003-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4722 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20040151740.pdf [firstpage_image] =>[orig_patent_app_number] => 10461829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638763 [patent_doc_number] => 20030211978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Method and composition for treatment of inflammatory bowel disease' [patent_app_type] => new [patent_app_number] => 10/459563 [patent_app_country] => US [patent_app_date] => 2003-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3814 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211978.pdf [firstpage_image] =>[orig_patent_app_number] => 10459563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 634153 [patent_doc_number] => 07129209 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-31 [patent_title] => 'Use of hydrophobic crosslinking agents to prepare crosslinked biomaterial compositions' [patent_app_type] => utility [patent_app_number] => 10/448246 [patent_app_country] => US [patent_app_date] => 2003-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8037 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/129/07129209.pdf [firstpage_image] =>[orig_patent_app_number] => 10448246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7403156 [patent_doc_number] => 20040023853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Antagonistic peptides of prostaglandin E2 receptor subtype EP4' [patent_app_type] => new [patent_app_number] => 10/444516 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10624 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023853.pdf [firstpage_image] =>[orig_patent_app_number] => 10444516 [rel_patent_id] =>[rel_patent_doc_number] =>)